ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,787.29
-1.64%
S&P 500
5,631.22
0.28%
Dow Jones
40,211.72
0.00%
US Dollar vs Yen
158.439
0.19%
Brent Oil
83.065
-1.51%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Vertex Pharmaceuticals Inc (VRTX)

  7. Vertex Pharmaceuticals Inc (VRTX) ニュース

VRTX

Vertex Pharmaceuticals (VRTX)

Vertex Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:VRTX
日付受信時刻ニュースソース見出しコード企業名
2023/02/2306 : 54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2023/02/2306 : 51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2023/02/2306 : 37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2023/02/2306 : 34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2023/02/2306 : 30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2023/02/2206 : 05Business WireVertex to Present at Cowen’s 43rd Annual Health Care Conference on March 7NASDAQ:VRTXVertex Pharmaceuticals Inc
2023/02/1706 : 20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2023/02/1706 : 16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2023/02/1507 : 31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2023/02/1507 : 29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2023/02/1507 : 22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2023/02/1507 : 19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2023/02/1507 : 16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2023/02/1507 : 16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2023/02/1507 : 14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2023/02/1404 : 52Edgar (US Regulatory)Schedule 13g
(sc 13g)		NASDAQ:VRTXVertex Pharmaceuticals Inc
2023/02/1106 : 14Edgar (US Regulatory)Annual Report (10-k)NASDAQ:VRTXVertex Pharmaceuticals Inc
2023/02/1002 : 43Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:VRTXVertex Pharmaceuticals Inc
2023/02/1002 : 14Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VRTXVertex Pharmaceuticals Inc
2023/02/0906 : 54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2023/02/0806 : 37Dow Jones NewsVertex Pharmaceuticals Sets $3 Billion Share Repurchase ProgramNASDAQ:VRTXVertex Pharmaceuticals Inc
2023/02/0806 : 08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRTXVertex Pharmaceuticals Inc
2023/02/0806 : 01Business WireVertex Reports Fourth Quarter and Full Year Financial 2022 ResultsNASDAQ:VRTXVertex Pharmaceuticals Inc
2023/02/0407 : 04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2023/02/0407 : 02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2023/02/0406 : 59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2023/02/0406 : 58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2023/02/0406 : 46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2023/02/0406 : 37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
2023/02/0406 : 37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRTXVertex Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:VRTX

最近閲覧した銘柄

AMEX
XLF
Financial Select Sector
USOTC
ADDYY
Adidas (QX)
NYSE
CVX
Chevron
USOTC
DTEGY
Deutsche Telekom (QX)
AMEX
XLV
Health Care Select Sector
NYSE
JPM
JP Morgan Chase
AMEX
XLE
Energy Select Sector SPDR
USOTC
BASFY
BASF (QX)
USOTC
RHHBY
Roche (QX)
COIN
SOLUSD
Solana
FX
USDEUR
US Dollar vs Euro
SPI
SP500
S&P 500
NYSE
AXP
American Express
COIN
ETHUSD
Ethereum
CCOM
US100
US Tech 100
CCOM
US30
US 30
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有